Researcher.Life Logo

European Neuropsychopharmacology : Impact Factor & More

eISSN: 1873-7862pISSN: 0924-977X

Key Metrics

CiteScore
6.9
Eigenfactor
0.01 - 0.05
H-Index
124
Impact Factor
5 - 10
SJR
Q1Neurology
SNIP
1.19
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on European Neuropsychopharmacology

European Neuropsychopharmacology Journal Specifications

Overview
Publisher ELSEVIER
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1990
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in European Neuropsychopharmacology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in European Neuropsychopharmacology

Is psychosis an obstetric condition? Revisiting the role of early-life environmentally stressful events
  • 1 Dec 2025
  • European Neuropsychopharmacology
Cell type-specific methylome-wide association studies of childhood ADHD symptoms.
  • 1 Dec 2025
  • European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Commentary on the article "Efficacy of pharmacogenetic-guided antidepressant treatment on functional outcomes and quality of life in adults with anxiety and affective disorders: A systematic review and meta-analysis".
  • 1 Dec 2025
  • European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Antidepressant use in pregnancy and neonatal outcomes: reassuring findings from an asian cohort
  • 1 Dec 2025
  • European Neuropsychopharmacology
Toward rigorous control conditions in trials of digital therapeutics
  • 1 Dec 2025
  • European Neuropsychopharmacology
Response to the letter regarding “Risk of manic switch and suicidal outcomes in bipolar depression treated with esketamine”
  • 1 Dec 2025
  • European Neuropsychopharmacology
Is psychosis an obstetric condition? Revisiting the role of early-life environmentally stressful events
  • 1 Dec 2025
  • European Neuropsychopharmacology
Cell type-specific methylome-wide association studies of childhood ADHD symptoms.
  • 1 Dec 2025
  • European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Commentary on the article "Efficacy of pharmacogenetic-guided antidepressant treatment on functional outcomes and quality of life in adults with anxiety and affective disorders: A systematic review and meta-analysis".
  • 1 Dec 2025
  • European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Antidepressant use in pregnancy and neonatal outcomes: reassuring findings from an asian cohort
  • 1 Dec 2025
  • European Neuropsychopharmacology
Toward rigorous control conditions in trials of digital therapeutics
  • 1 Dec 2025
  • European Neuropsychopharmacology
Response to the letter regarding “Risk of manic switch and suicidal outcomes in bipolar depression treated with esketamine”
  • 1 Dec 2025
  • European Neuropsychopharmacology

FAQs on European Neuropsychopharmacology